Blogs

Injection Pen Research Studies, 2026

2 min read

Research studies on injection pens highlight advancements in connected insulin pen technologies, focusing on improved injection timing, medication adherence, glycaemic control, patient outcomes, and dose accuracy.

Injection Pen Research Studies, 2026
  1. Connected Smart Pen Cap and Glycaemic Control

Research Title Analysis of Glycaemic Control and Treatment Satisfaction with a Connected Smart Pen Cap in Adults with Type 1 Diabetes: A Randomised, Open-Label, Parallel-Group Trial

Journal

Diabetologia, May 2026

Research Focus

Evaluates the effectiveness of connected insulin pen caps in improving glycaemic control and treatment satisfaction.

Key Findings

The trial included 42 participants. Connected pen caps reduced time spent in severe hyperglycaemia and glucose variability compared with non-connected caps. The study also reported reduced hypoglycaemia avoidance behaviours.

Source

PubMed – PMID: 41634174

  1. Connected Insulin Cap and Injection Timing

Research Title Improvement in Insulin Injection Timing and Glucometrics Using a Connected Insulin Cap: The Insulclock v2.0 Prospective Study

Journal

 

Frontiers in Endocrinology, July 2026

Research Focus

Examines the impact of connected insulin pen caps on injection timing, insulin adherence, and glucose management.

Key Findings

Among 52 participants completing the study, time in range improved from 56.9% to 61.9%, while on-time insulin injections increased from 45.5% to 54.4% during the active monitoring phase.

Source

PubMed – PMID: 42528822

  1. Smart Insulin Pens Versus Automated Insulin Delivery

Research Title Technology Choice, Glycemic Control and Patient-Reported Outcome Measures in Adults with Type 1 Diabetes: A Randomized Crossover Trial Comparing a Smart Insulin Pen with an Automated Insulin Delivery System (EBIACE-1)

Journal

Diabetes Research and Clinical Practice, September 2026

Research Focus

Compares smart insulin pens with automated insulin delivery systems in adults with type 1 diabetes.

Key Findings

The study involved 31 adults. Automated insulin delivery achieved higher time in range (81% versus 66%), although 46% of participants achieved near-optimal glycaemic control using smart insulin pens.

Source

PubMed – PMID: 42612915

  1. Efficacy and Safety of Connected Insulin Pens

Research Title Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol (SMART-5 Study)

Journal

Endocrinology and Metabolism, June 2026

Research Focus

Investigates advanced connected insulin pens incorporating continuous glucose monitoring, individualized dose recommendations, and digital coaching.

Key Findings

The study protocol outlines a randomized trial involving 152 participants. It will evaluate whether advanced connected insulin pens improve HbA1c compared with conventional tracking insulin pens. Results are not yet established by this protocol.

Source

PubMed – PMID: 41391451

  1. Dose Accuracy of Connected Insulin Pens

Research Title Dose Accuracy and Reliability of a Connected Insulin Pen System

Journal

Journal of Diabetes Science and Technology, March 2026 issue

Research Focus

Evaluates dose accuracy, reliability, and data transmission capabilities of the Tempo connected insulin pen system.

Key Findings

The system met ISO 11608-1:2014 dose-accuracy requirements across three tested dose levels. Its connected module also reliably detected, stored, and transmitted insulin dosing information.

Source

PubMed – PMID: 39881439

Share this article
STRAITS RESEARCH INTELLIGENCE

Explore the Related Market Research

Explore market analysis, competitive insights, and industry forecasts.

View Full Report